Hasko G, Linden J, Cronstein B, Pacher P: Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov. 2008, 7: 759-770. 10.1038/nrd2638.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dionisotti S, Ferrara S, Molta C, Zocchi C, Ongini E: Labeling of A(2A) adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [H-3]SCH 58261. J Pharmacol Exp Ther. 1996, 278: 1209-1214.
CAS
PubMed
Google Scholar
Link AA, Kino T, Worth JA, McGuire JL, Crane ML, Chrousos GP, Wilder RL, Elenkov IJ: Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes. J Immunol. 2000, 164: 436-442.
Article
CAS
PubMed
Google Scholar
Lohse MJ, Maurer K, Gensheimer HP, Schwabe U: Dual Actions of Adenosine on Rat Peritoneal Mast-Cells. Naunyn-Schmiedebergs Arch Pharmacol. 1987, 335: 555-560.
Article
CAS
PubMed
Google Scholar
Fenster MS, Shepherd RK, Linden J, Duling BR: Activation of adenosine A(2 alpha) receptors inhibits mast cell degranulation and mast cell-dependent vasoconstriction. Microcirculation. 2000, 7: 129-135.
CAS
PubMed
Google Scholar
Walker BAM, Rocchini C, Boone RH, Ip S, Jacobson MA: Adenosine A(2a) receptor activation delays apoptosis in human neutrophils. J Immunol. 1997, 158: 2926-2931.
CAS
PubMed
Google Scholar
Varani K, Gessi S, Dionisotti S, Ongini E, Borea PA: [H-3]-SCH 58261 labelling of functional A(2A) adenosine receptors in human neutrophil membranes. Br J Pharmacol. 1998, 123: 1723-1731. 10.1038/sj.bjp.0701758.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sullivan GW, Linden J, Buster BL, Scheld WM: Neutrophil A2A adenosine receptor inhibits inflammation in a rat model of meningitis: synergy with the type IV phosphodiesterase inhibitor, rolipram. J Infect Dis. 1999, 180: 1550-1560. 10.1086/315084.
Article
CAS
PubMed
Google Scholar
Lappas CM, Rieger JM, Linden J: A(2A) adenosine receptor induction inhibits IFN-gamma production in murine CD4(+) T cells. J Immunol. 2005, 174: 1073-1080.
Article
CAS
PubMed
Google Scholar
Koshiba M, Rosin DL, Hayashi N, Linden J, Sitkovsky MV: Patterns of A(2A) extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. FASEB J. 1999, 13: A944-
Google Scholar
Huang S, Apasov S, Koshiba M, Sitkovsky M: Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood. 1997, 90: 1600-1610.
CAS
PubMed
Google Scholar
Fredholm BB: Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 2007, 14: 1315-1323. 10.1038/sj.cdd.4402132.
Article
CAS
PubMed
Google Scholar
Day YJ, Li Y, Rieger JM, Ramos SI, Okusa MD, Linden J: A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury. J Immunol. 2005, 174: 5040-5046.
Article
CAS
PubMed
Google Scholar
Lappas CM, Sullivan GW, Linden J: Adenosine A2A agonists in development for the treatment of inflammation. Expert Opin Investig Drugs. 2005, 14: 797-806. 10.1517/13543784.14.7.797.
Article
CAS
PubMed
Google Scholar
Li Y, Oskouian RJ, Day YJ, Rieger JM, Liu L, Kern JA, Linden J: Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow-derived cells or deletion of the A2A receptor on non-bone marrow-derived cells. Neuroscience. 2006, 141: 2029-2039. 10.1016/j.neuroscience.2006.05.014.
Article
CAS
PubMed
Google Scholar
Linden J: Adenosine in tissue protection and tissue regeneration. Mol Pharmacol. 2005, 67: 1385-1387. 10.1124/mol.105.011783.
Article
CAS
PubMed
Google Scholar
Hogan CJ, Fang GD, Scheld WM, Linden J, Diduch DR: Inhibiting the inflammatory response in joint sepsis. Arthroscopy. 2001, 17: 311-315. 10.1053/jars.2001.21492.
Article
PubMed
Google Scholar
Moore CC, Martin EN, Lee GH, Obrig T, Linden J, Scheld WM: An A2A adenosine receptor agonist, ATL313, reduces inflammation and improves survival in murine sepsis models. BMC Infect Dis. 2008, 8: 141-10.1186/1471-2334-8-141.
Article
PubMed
PubMed Central
Google Scholar
Sullivan GW, Fang G, Linden J, Scheld WM: A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. J Infect Dis. 2004, 189: 1897-1904. 10.1086/386311.
Article
CAS
PubMed
Google Scholar
Cavalcante IC, Castro MV, Barreto AR, Sullivan GW, Vale M, Almeida PR, Linden J, Rieger JM, Cunha FQ, Guerrant RL, Ribeiro RA, Brito GA: Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis. Infect Immun. 2006, 74: 2606-2612. 10.1128/IAI.74.5.2606-2612.2006.
Article
CAS
PubMed
PubMed Central
Google Scholar
de Araujo Junqueira AF, Dias AA, Vale ML, Spilborghs GM, Bossa AS, Lima BB, Carvalho AF, Guerrant RL, Ribeiro RA, Brito GA: Adenosine deaminase inhibition prevents Clostridium difficile toxin A-induced enteritis in mice. Infect Immun. 2011, 79: 653-662. 10.1128/IAI.01159-10.
Article
PubMed
Google Scholar
Warren CA, Calabrese GM, Li Y, Pawlowski SW, Figler RA, Rieger J, Ernst PB, Linden J, Guerrant RL: Effects of adenosine A(2)A receptor activation and alanyl-glutamine in Clostridium difficile toxin-induced ileitis in rabbits and cecitis in mice. BMC Infect Dis. 2012, 12: 13-10.1186/1471-2334-12-13.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen JF, Huang Z, Ma J, Zhu J, Moratalla R, Standaert D, Moskowitz MA, Fink JS, Schwarzschild MA: A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci. 1999, 19: 9192-9200.
CAS
PubMed
Google Scholar
Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, Kelly CP: A mouse model of Clostridium difficile-associated disease. Gastroenterology. 2008, 135: 1984-1992. 10.1053/j.gastro.2008.09.002.
Article
PubMed
Google Scholar
Murphree LJ, Marshall MA, Rieger JM, Macdonald TL, Linden J: Human A(2A) adenosine receptors: High affinity agonist binding to receptor-G protein complexes containing G beta 4. Drug Dev Res. 2002, 56: 573-
Google Scholar
Cheng Y, Prusoff WH: Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973, 22: 3099-3108. 10.1016/0006-2952(73)90196-2.
Article
CAS
PubMed
Google Scholar
Zar FA, Bakkanagari SR, Moorthi KM, Davis MB: A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis. 2007, 45: 302-307. 10.1086/519265.
Article
CAS
PubMed
Google Scholar
Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH: Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol. 2010, 31: 431-455. 10.1086/651706.
Article
PubMed
Google Scholar
Tannock GW, Munro K, Taylor C, Lawley B, Young W, Byrne B, Emery J, Louie T: A new macrocyclic antibiotic, fidaxomicin (OPT-80), causes less alteration to the bowel microbiota of Clostridium difficile-infected patients than does vancomycin. Microbiology. 2010, 156: 3354-3359. 10.1099/mic.0.042010-0.
Article
CAS
PubMed
Google Scholar
Sun X, Wang H, Zhang Y, Chen K, Davis B, Feng H: Mouse relapse model of Clostridium difficile infection. Infect Immun. 2011, 79: 2856-2864. 10.1128/IAI.01336-10.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ye JH, Rajendran VM: Adenosine: an immune modulator of inflammatory bowel diseases. World J Gastroenterol. 2009, 15: 4491-4498. 10.3748/wjg.15.4491.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ramakers BP, Pickkers P, Deussen A, Rongen GA, van den Broek P, van der Hoeven JG, Smits P, Riksen NP: Measurement of the endogenous adenosine concentration in humans in vivo: methodological considerations. Curr Drug Metab. 2008, 9: 679-685. 10.2174/138920008786049249.
Article
CAS
PubMed
Google Scholar
Kimura Y, Turner JR, Braasch DA, Buddington RK: Lumenal adenosine and AMP rapidly increase glucose transport by intact small intestine. Am J Physiol Gastrointest Liver Physiol. 2005, 289: G1007-G1014. 10.1152/ajpgi.00085.2005.
Article
CAS
PubMed
Google Scholar
Di PR, Melani A, Esposito E, Mazzon E, Paterniti I, Bramanti P, Pedata F, Cuzzocrea S: Adenosine A2A receptor-selective stimulation reduces signaling pathways involved in the development of intestine ischemia and reperfusion injury. Shock. 2010, 33: 541-551.
Google Scholar
Antonioli L, Fornai M, Colucci R, Awwad O, Ghisu N, Tuccori M, Da SF, La MC, Natale G, Duranti E, Virdis A, Blandizzi C: The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors. J Pharmacol Exp Ther. 2010, 335: 434-442. 10.1124/jpet.110.171223.
Article
CAS
PubMed
Google Scholar
Thiel M, Chambers JD, Chouker A, Fischer S, Zourelidis C, Bardenheuer HJ, Arfors KE, Peter K: Effect of adenosine on the expression of beta(2) integrins and L-selectin of human polymorphonuclear leukocytes in vitro. J Leukoc Biol. 1996, 59: 671-682.
CAS
PubMed
Google Scholar
Cronstein BN, Levin RI, Philips M, Hirschhorn R, Abramson SB, Weissmann G: Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol. 1992, 148: 2201-2206.
CAS
PubMed
Google Scholar
Cronstein BN, Rosenstein ED, Kramer SB, Weissmann G, Hirschhorn R: Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol. 1985, 135: 1366-1371.
CAS
PubMed
Google Scholar
Sullivan GW, Rieger JM, Scheld WM, Macdonald TL, Linden J: Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists. Br J Pharmacol. 2001, 132: 1017-1026. 10.1038/sj.bjp.0703893.
Article
CAS
PubMed
PubMed Central
Google Scholar
Richter J: Effect of adenosine analogues and cAMP-raising agents on TNF-, GM-CSF-, and chemotactic peptide-induced degranulation in single adherent neutrophils. J Leukoc Biol. 1992, 51: 270-275.
CAS
PubMed
Google Scholar
Thiel M, Chouker A: Acting via A2 receptors, adenosine inhibits the production of tumor necrosis factor-alpha of endotoxin-stimulated human polymorphonuclear leukocytes. J Lab Clin Med. 1995, 126: 275-282.
CAS
PubMed
Google Scholar
Pawlowski SW, Calabrese G, Kolling GL, Freire R, Alcantara Warren C, Liu B, Sartor B, Guerrant RL: Murine model of Clostridium difficile infection using gnotobiotic aged C57Bl/6 mice and a BI strain. J Infect Dis. 2010, 202: 1708-1712. 10.1086/657086. Erratum in: J Infect Dis 2011,203:1505. Platts-Mills, J [added]
Article
CAS
PubMed
PubMed Central
Google Scholar
Smail EH, Cronstein BN, Meshulam T, Esposito AL, Ruggeri RW, Diamond RD: In vitro, Candida albicans releases the immune modulator adenosine and a second, high-molecular weight agent that blocks neutrophil killing. J Immunol. 1992, 148: 3588-3595.
CAS
PubMed
Google Scholar
Thammavongsa V, Kern JW, Missiakas DM, Schneewind O: Staphylococcus aureus synthesizes adenosine to escape host immune responses. J Exp Med. 2009, 206: 2417-2427. 10.1084/jem.20090097.
Article
CAS
PubMed
PubMed Central
Google Scholar
Warren CA, Li Y, Calabrese GM, Freire RS, Zaja-Milatovic S, van Opstal E, Figler RA, Linden J, Guerrant RL: Contribution of Adenosine A2B Receptors in Clostridium difficile Intoxication and Infection. Infect Immun. 2012, Oct 8. [Epub ahead of print]
Google Scholar
Strohmeier GR, Reppert SM, Lencer WI, Madara JL: The A2b adenosine receptor mediates cAMP responses to adenosine receptor agonists in human intestinal epithelia. J Biol Chem. 1995, 270: 2387-2394. 10.1074/jbc.270.5.2387.
Article
CAS
PubMed
Google Scholar